InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Behrenbruch Christian, Chief Executive Officer. Director active across 1 companies, notably Telix Pharmaceuticals Ltd. Cumulatively, 2 disclosures have been published. Total volume traded: €853k. The latest transaction was filed on 28 April 2026 — Acquisition. Regulator: SEC (Form 4). The full history is free.
Declarations2 total
US$426,32534,500 shares@ US$12.35720.017% mcap100.0% of flow
Ordinary Shares
SEC:0001628280-26-031608·
Ideal exit: 23 Jan 2027 (T+270)
€426,32534,500 shares@ €12.35720.017% mcap50.0% of flow
Ordinary Shares
SEC:0001628280-26-031608:0·
Ideal exit: 23 Jan 2027 (T+270)
2 of 2 declarations
About Behrenbruch Christian
Christian Behrenbruch is the MD & Group CEO at Telix Pharmaceuticals Ltd. He leads the company's operations and development strategies, ensuring its growth and profitability. His experience in the pharmaceutical sector enables him to navigate effectively in a complex environment.
